Probiotics: An overview of beneficial effects

Antonie van Leeuwenhoek, International Journal of General and Molecular Microbiology

Volumn 82, Issue 1-4, 2002, Pages 279-289

  Ouwehand, Arthur C ^a   Salminen, Seppo ^a   Isolauri, Erika ^b  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Health effects; Lactic acid bacteria; Probiotics

Indexed keywords

ANTIBIOTIC AGENT; BETA GALACTOSIDASE; CYTOKINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; INTERLEUKIN 10; LACTIC ACID; LACTOSE; PROBIOTIC AGENT; TRANSFORMING GROWTH FACTOR BETA;

BACTERIUM; LACTIC ACID; PROBIOTICS;

ARTICLE; ATOPY; BACILLUS; BACTERIAL STRAIN; BIFIDOBACTERIUM; CHILD; CLINICAL TRIAL; COLORECTAL CANCER; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFECT; DRUG USE; ENTERITIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; GASTROINTESTINAL TRACT; HUMAN; LACTIC ACID BACTERIUM; LACTOBACILLUS; LACTOSE INTOLERANCE; NONHUMAN; PRIORITY JOURNAL; RNA VIRUS INFECTION; ROTAVIRUS; SACCHAROMYCES CEREVISIAE;

BACILLUS; BIFIDOBACTERIUM; GASTROINTESTINAL DISEASES; HEALTH PROMOTION; HUMANS; LACTOBACILLUS; PROBIOTICS; SACCHAROMYCES CEREVISIAE;

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM; ENTEROCOCCUS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; LACTOBACILLUS; RNA VIRUSES; ROTAVIRUS; SACCHAROMYCES; SACCHAROMYCES CEREVISIAE;

EID: 0036693761     PISSN: 00036072     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020620607611     Document Type: Article

References (83)

1. BLP Study Group Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial
2. Composition for treating acne
3. Human faecal flora in health and colon cancer
4. Effects of Lactobacillus GG yogurt on human intestinal microecology in Japanese subjects
5. Prophylactic efficacy of lactobacilli on travelers diarrhea
6. Effect of lactic acid producing bacteria on the human intestinal microflora during ampicillin treatment
7. Molecular and cellular aspects of the secretory immunoglobulin system
8. Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiotia in patients with irritable bowel syndrome or functional diarrhea
9. Flow cytometric assessment of viability of lactic acid bacteria
10. Protective effect of intranasally inocculated Lactobacillus fermentum against Streptococcus pneumoniae challenge on the mouse respiratory tract
11. Global progress in the control of diarrheal disease
12. Horseradish peroxidase transport across rabbit jejunum and Peyer's patches in vitro
13. Attachment of Lactobacillus casei strain GG to human colon carcinoma cell line Caco-2: Comparison with other dairy strains
14. Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man
15. Probiotics in man and animals
16. Probiotic supplementation to enhance natural immunity in the elderly: Effects of a newly characterized immunomodulatory strain Lactobacillus rhamnosus HN001 (DR20™) on leucocyte phagocytosis
17. Review of probiotics available to modify gastrointestinal flora
18. Health benefits of probiotics
19. Diet and cancer prevention
20. Importance of intestinal colonisation in the maturation of humoral immunity in early infancy: A prospective follow up study of healthy infants aged 0-6 months
21. Regulatory T cells and inflammatory bowel disease
22. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: A multicenter European trial
23. Probiotics
24. Is Lactobacillus GG helpful in children with Crohn's disease? Results of a preliminary, open-label study
25. Saccharomyces boulardii in maintenance treatment of Crohn's disease
26. Non-pathogenic bacteria elicit differential cytokine response by intestinal epithelial cell/Leukocyte co-cultures
27. A review of clinical trials of probiotics in the management of inflammatory bowel diesease
28. Deficiencies in microbiological quality and labellinf of probiotic supplements
29. Effect of long term consumption of probiotic milk on infections in children attending day care centres: Double blind randomised trial
30. Microbial colonization influences composition and T-cell receptor V beta repertoire of intraepithelial lymphocytes in rat intestine
31. Cytokine-induced alteration of the epithelial barrier to food antigens in disease
32. Ingestion of yoghurt containing Lactobacillus acidophilus as prophylaxis for candidal vaginitis
33. The role of probiotic bacteria in cancer prevention
34. Probiotics and gut inflammation
35. Probiotics in human disease
36. Diet during rotavirus enteritis affects jejunal permeability to macromolecules in suckling rats
37. Probiotics in the management of atopic eczema
38. Probiotics: Effects on immunity
39. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain
40. Viable versus inactivated Lactobacillus strain GG in acute rotavirus diarrhoea
41. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing
42. Probiotics in primary prevention of atopic disease: A randomised placebo-controlled trial
43. The role of intestinal gas in functional abdominal pain
44. The effect of unabsorbed sucrose and mannitol on the small intestinal flow rate and mean transit time
45. Modulation of a specific Immoral immune response and changes in intestinal flora mediated through fermented mik intake
46. The reaction of the immune system to pathogens but not food antigens and commensal bacteria
47. Probiotics: A novel approach in the management of food allergy
48. Crohn's disease and Echerichia coli
49. Probiotics: Towards demonstrating efficacy
50. Recovery of Lactobacillus strain GG (ATCC 53103) from saliva of healthy volunteers after consumption of yoghurt prepared with the bacterium
51. Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the immune system in healthy human subjects
52. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299v in patients with irritable bowel syndrome
53. The health effects of cultured milk products with viable and non-viabel bacteria
54. Adhesion of four Bifidobacterium strains to human intestinal mucus from subjects in different age groups
55. The effect of digestive enzymes on the adhesion of probiotic bacteria in vitro
56. Disease dependent adhesion of lactic acid bacteria to colonic tissue in vitro
57. Suppression of T cell activation by Lactobacillus rhamnosus GG-degraded bovine casein
58. Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG
59. A randomized clinical trial of the effect of yoghurt on the human salivary microflora
60. Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microflora
61. Influence of three day antimicrobial therapy and Lactobacillus vaginal suppositories on recurrence of urinary tract infections
62. Probiotic agents to protect the urogenital tract against infection
63. Oral probiotics can resolve urogenital infections
64. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus
65. Pathogenesis of gut virus infection
66. Clinical uses of probiotics for stabilizing the gut mucosal barrier: Successful strains and future challenges
67. Functional food science and gastrointestinal physiology and function
68. Probiotics: How should they be defined?
69. Uptake and transport of macro-molecules by the intestine: Possible role in clinical disorders (an update)
70. Microflora of patients with stool abnormality
71. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis
72. The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans
73. Hay fever, hygiene, and household size
74. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction
75. Efficacy of Lactobacillus preparation Biolactis powder in children with rotavirus enteritis
76. Prevention of antibiotic associated diarrhoea by Saccharomyces boulardii: A prospective study
77. Downregulation of antiCD3 antibody-induced IL-4 production by bovine caseins hydrolysed with Lactobacillus GG-derived enzymes
78. Identification and antibiotic resistance of isolates from probiotic products
79. Chemical, physical and enzymatic pre-treatments of probiotic lactobacilli alter their adhesion to human intestinal mucus glycoproteins
80. Quality assurence criteria for probiotic bacteria
81. Lactose intolerance
82. Determination of complement-mediated killing of bacteria by viability staining and bioluminescence